Michelson G, Ruprecht K W, Lang G K
Augenklinik mit Poliklinik der Universität Erlangen-Nürnberg.
Klin Monbl Augenheilkd. 1988 Oct;193(4):360-3. doi: 10.1055/s-2008-1050270.
Clinical data of 69 patients due to undergo ECCE with PCIOL implantation were evaluated in a standardized fashion. The preliminary results show that the blood pressure measured preoperatively and intraoperatively necessitated antihypertensive therapy. The averaged systolic blood pressure in the ward was 147.2 +/- 20.4 mm Hg; before retrobulbar anesthesia 159.9 +/- 30.4 mm Hg; after retrobulbar anesthesia 172.6 +/- 24.2 mm Hg; and at the start of surgery 154.2 +/- 18.4 mm Hg. Maximum intraoperative blood pressure was 156.2 +/- 20.7 mm Hg; at the end of surgery it was 144.3 +/- 19.5 mm Hg. In 12 patients (17%), systolic blood pressure higher than 200 mm Hg was measured after retrobulbar anesthesia. Antihypertensive therapy (nifedipine, nitroglycerin) was initiated in 44 patients (64%). These data support the recommendation that blood pressure should be monitored continuously both before and during the operation in order to minimize the rate of surgical and general complications.
对69例拟行超声乳化白内障吸除联合人工晶状体植入术的患者的临床资料进行了标准化评估。初步结果显示，术前和术中测量的血压需要进行抗高血压治疗。病房内平均收缩压为147.2±20.4mmHg；球后麻醉前为159.9±30.4mmHg；球后麻醉后为172.6±24.2mmHg；手术开始时为154.2±18.4mmHg。术中最高血压为156.2±20.7mmHg；手术结束时为144.3±19.5mmHg。12例患者（17%）在球后麻醉后收缩压高于200mmHg。44例患者（64%）开始进行抗高血压治疗（硝苯地平、硝酸甘油）。这些数据支持了在手术前和手术期间应持续监测血压以尽量降低手术和全身并发症发生率的建议。
